drugset / Trial / NCT02118714
Atrasentan Spermatogenesis and Testicular Function
NaSingle-groupOpen-labelOther
Summary
This study is being conducted to evaluate the effects of Atrasentan on sperm production and testicular function in male subjects with Type 1 or 2 Diabetes and Nephropathy. This study included 2 periods: a Treatment Period (up to 26 weeks) followed by an Observational Period (up to an additional 52 weeks).
Timeline
- Start
- 2015-04-06
- Primary completion
- 2018-04-18
- Completion
- 2018-07-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atrasentan | Other / unclassified | 0.75 mg | Oral |